USD 24.89
(-2.16%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 3.46 Billion USD | -18.56% |
2022 | 3.39 Billion USD | 11.72% |
2021 | 3.03 Billion USD | 5.6% |
2020 | 2.87 Billion USD | -4.39% |
2019 | 3 Billion USD | 8.47% |
2018 | 2.77 Billion USD | 7.23% |
2017 | 2.58 Billion USD | 13.02% |
2016 | 2.28 Billion USD | -20.91% |
2015 | 2.89 Billion USD | 5.08% |
2014 | 2.75 Billion USD | 11.5% |
2013 | 2.47 Billion USD | 11.21% |
2012 | 2.22 Billion USD | -2.07% |
2011 | 2.26 Billion USD | 12.78% |
2010 | 2.01 Billion USD | -0.4% |
2009 | 2.01 Billion USD | -2.93% |
2008 | 2.08 Billion USD | 17.78% |
2007 | 1.76 Billion USD | 21.54% |
2006 | 1.45 Billion USD | 8.03% |
2005 | 1.34 Billion USD | 4.91% |
2004 | 1.28 Billion USD | 17.1% |
2003 | 1.09 Billion USD | -27.82% |
2002 | 1.51 Billion USD | 80.71% |
2001 | 839.35 Million USD | -47.65% |
2000 | 1.6 Billion USD | -2.56% |
1999 | 1.64 Billion USD | 8.86% |
1998 | 1.51 Billion USD | 4.26% |
1997 | 1.44 Billion USD | -4.52% |
1996 | 1.51 Billion USD | 14.08% |
1995 | 1.33 Billion USD | 31.04% |
1994 | 1.01 Billion USD | -13.94% |
1993 | 1.18 Billion USD | 6.85% |
1992 | 1.1 Billion USD | -1.02% |
1991 | 1.11 Billion USD | -20.71% |
1990 | 1.4 Billion USD | 23.53% |
1989 | 1.13 Billion USD | 5.76% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.64 Billion USD | 0.0% |
2023 Q2 | 1.58 Billion USD | 0.0% |
2023 Q4 | 1.46 Billion USD | 0.0% |
2023 FY | 2.76 Billion USD | -18.56% |
2022 Q2 | 1.49 Billion USD | 0.0% |
2022 FY | 3.39 Billion USD | 11.72% |
2022 Q4 | 1.55 Billion USD | 0.0% |
2021 Q2 | 1.42 Billion USD | 0.0% |
2021 FY | 3.03 Billion USD | 5.6% |
2021 Q4 | 1.49 Billion USD | 0.0% |
2020 Q4 | 1.32 Billion USD | 0.0% |
2020 FY | 2.87 Billion USD | -4.39% |
2020 Q2 | 1.3 Billion USD | 0.0% |
2019 Q2 | 1.36 Billion USD | 0.0% |
2019 Q4 | 1.42 Billion USD | 0.0% |
2019 FY | 3 Billion USD | 8.47% |
2018 Q2 | 1.42 Billion USD | 0.0% |
2018 FY | 2.77 Billion USD | 7.23% |
2018 Q4 | 1.35 Billion USD | 0.0% |
2017 FY | 2.58 Billion USD | 13.02% |
2017 Q2 | 1.32 Billion USD | 0.0% |
2017 Q4 | 1.26 Billion USD | 0.0% |
2016 Q4 | 944 Million USD | 0.0% |
2016 Q2 | 1.34 Billion USD | 0.0% |
2016 FY | 2.28 Billion USD | -20.91% |
2015 FY | 2.89 Billion USD | 5.08% |
2015 Q4 | 1.61 Billion USD | 0.0% |
2015 Q2 | 1.27 Billion USD | 0.0% |
2014 Q2 | 1.32 Billion USD | 0.0% |
2014 Q4 | 1.42 Billion USD | 0.0% |
2014 FY | 2.75 Billion USD | 11.5% |
2013 Q2 | 1.22 Billion USD | 0.0% |
2013 FY | 2.47 Billion USD | 11.21% |
2013 Q4 | 1.25 Billion USD | 0.0% |
2012 Q1 | 572 Million USD | -4.03% |
2012 Q4 | 574 Million USD | 10.17% |
2012 Q2 | 554 Million USD | -3.15% |
2012 Q3 | 521 Million USD | -5.96% |
2012 FY | 2.22 Billion USD | -2.07% |
2011 Q2 | 564 Million USD | 2.92% |
2011 FY | 2.26 Billion USD | 12.78% |
2011 Q4 | 596 Million USD | 6.43% |
2011 Q3 | 560 Million USD | -0.71% |
2011 Q1 | 548 Million USD | 6.41% |
2010 FY | 2.01 Billion USD | -0.4% |
2010 Q4 | 515 Million USD | 5.1% |
2010 Q3 | 490 Million USD | -3.35% |
2010 Q2 | 507 Million USD | 1.6% |
2010 Q1 | 499 Million USD | -13.37% |
2009 Q3 | 483 Million USD | -0.62% |
2009 Q2 | 486 Million USD | 2.53% |
2009 Q1 | 474 Million USD | -17.85% |
2009 Q4 | 576 Million USD | 19.25% |
2009 FY | 2.01 Billion USD | -2.93% |
2008 Q4 | 577 Million USD | 16.57% |
2008 Q2 | 539 Million USD | 11.59% |
2008 Q3 | 495 Million USD | -8.16% |
2008 Q1 | 483 Million USD | -25.23% |
2008 FY | 2.08 Billion USD | 17.78% |
2007 Q2 | 423 Million USD | 3.93% |
2007 Q1 | 407 Million USD | 3.56% |
2007 Q3 | 506 Million USD | 19.62% |
2007 Q4 | 646 Million USD | 27.67% |
2007 FY | 1.76 Billion USD | 21.54% |
2006 Q2 | 363 Million USD | 4.91% |
2006 FY | 1.45 Billion USD | 8.03% |
2006 Q4 | 393 Million USD | 7.38% |
2006 Q3 | 366 Million USD | 0.83% |
2006 Q1 | 346 Million USD | 291.33% |
2005 Q1 | 351 Million USD | -16.3% |
2005 Q3 | 286.71 Million USD | -15.37% |
2005 Q4 | -180.83 Million USD | -163.07% |
2005 Q2 | 338.78 Million USD | -3.48% |
2005 FY | 1.34 Billion USD | 4.91% |
2004 Q3 | 301.74 Million USD | 0.61% |
2004 FY | 1.28 Billion USD | 17.1% |
2004 Q4 | 419.36 Million USD | 38.98% |
2004 Q1 | 300.22 Million USD | 0.19% |
2004 Q2 | 299.92 Million USD | -0.1% |
2003 Q3 | 8.38 Million USD | -98.47% |
2003 Q1 | 235.91 Million USD | 67116042.53% |
2003 Q4 | 299.66 Million USD | 3472.94% |
2003 FY | 1.09 Billion USD | -27.82% |
2003 Q2 | 548.88 Million USD | 132.67% |
2002 FY | 1.51 Billion USD | 80.71% |
2002 Q2 | -696.59 Million USD | 0.0% |
2002 Q3 | - USD | 100.0% |
2002 Q4 | -351.50 USD | 0.0% |
2002 Q1 | - USD | 100.0% |
2001 Q4 | -1.34 Billion USD | 0.0% |
2001 Q1 | - USD | 100.0% |
2001 FY | 839.35 Million USD | -47.65% |
2001 Q3 | - USD | 100.0% |
2001 Q2 | -588.39 Million USD | 0.0% |
2000 Q2 | -627.02 Million USD | 0.0% |
2000 FY | 1.6 Billion USD | -2.56% |
2000 Q3 | - USD | 100.0% |
2000 Q1 | - USD | 100.0% |
2000 Q4 | -1.28 Billion USD | 0.0% |
1999 Q2 | 24.3 Million USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1999 FY | 1.64 Billion USD | 8.86% |
1999 Q4 | -1.5 Billion USD | 0.0% |
1999 Q3 | - USD | -100.0% |
1998 FY | 1.51 Billion USD | 4.26% |
1997 FY | 1.44 Billion USD | -4.52% |
1996 FY | 1.51 Billion USD | 14.08% |
1995 FY | 1.33 Billion USD | 31.04% |
1994 FY | 1.01 Billion USD | -13.94% |
1993 FY | 1.18 Billion USD | 6.85% |
1992 FY | 1.1 Billion USD | -1.02% |
1991 FY | 1.11 Billion USD | -20.71% |
1990 FY | 1.4 Billion USD | 23.53% |
1989 FY | 1.13 Billion USD | 5.76% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Abbott Laboratories | 15.71 Billion USD | 77.934% |
Allurion Technologies Inc. | 120.57 Million USD | -2775.389% |
Artivion, Inc. | 223.43 Million USD | -1451.689% |
Avanos Medical, Inc. | 375.5 Million USD | -823.302% |
Butterfly Network, Inc. | 162.46 Million USD | -2033.985% |
Butterfly Network, Inc. | 162.46 Million USD | -2033.985% |
Bio-Rad Laboratories, Inc. | 1.04 Billion USD | -230.963% |
Boston Scientific Corporation | 7.47 Billion USD | 53.637% |
Perspective Therapeutics, Inc. | 17.42 Million USD | -19795.558% |
CONMED Corporation | 564.24 Million USD | -514.453% |
Edwards Lifesciences Corporation | 3.09 Billion USD | -12.168% |
Paragon 28, Inc. | 210.1 Million USD | -1550.167% |
Glaukos Corporation | 367.83 Million USD | -842.54% |
Globus Medical, Inc. | 887.16 Million USD | -290.798% |
Inspire Medical Systems, Inc. | 568.49 Million USD | -509.857% |
Integer Holdings Corporation | 250.95 Million USD | -1281.501% |
Medtronic plc | 16.12 Billion USD | 78.505% |
Nevro Corp. | 389.36 Million USD | -790.417% |
Owlet, Inc. | 51.21 Million USD | -6668.972% |
Penumbra, Inc. | 590.87 Million USD | -486.755% |
Vicarious Surgical Inc. | 80.66 Million USD | -4197.969% |
Sonendo, Inc. | 68.46 Million USD | -4963.901% |
STERIS plc | 1.4 Billion USD | -147.579% |
Stryker Corporation | 9.2 Billion USD | 62.352% |
Vapotherm, Inc. | 66.02 Million USD | -5151.041% |
Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | -5.83% |